Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. NSE India Stock Exchange
  5. Solara Active Pharma Sciences Limited
  6. News
  7. Summary
    SOLARA   INE624Z01016

SOLARA ACTIVE PHARMA SCIENCES LIMITED

(SOLARA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Solara Active Pharma Sciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021

05/06/2021 | 03:44am EDT

Solara Active Pharma Sciences Limited announced earnings results for the fourth quarter ended March 31, 2021. For the fourth quarter, the company announced total revenue was INR 4,539.9 million compared to INR 3,089 million a year ago. Net income was INR 566.5 million compared to INR 178.2 million a year ago. Basic earnings per share from continuing operations was INR 15.57 compared to INR 6.78 a year ago. Diluted earnings per share from continuing operations was INR 15.24 compared to INR 6.21 a year ago. For the full year, total revenue was INR 16,456.5 million compared to INR 13,492.7 million a year ago. Net income was INR 2,214 million compared to INR 1,146.1 million a year ago. Basic earnings per share from continuing operations was INR 69 compared to INR 44.29 a year ago. Diluted earnings per share from continuing operations was INR 64.52 compared to INR 42.82 a year ago.


ę S&P Capital IQ 2021
All news about SOLARA ACTIVE PHARMA SCIENCES LIMITED
08/26Solara Active Pharma Sciences Limited Approves Final Dividend for the Financial Year En..
CI
08/04Aditya Puri Joins Solara Active Pharma's Board as Chairperson
CI
08/04Solara Active Pharma Sciences Limited Announces Board Changes
CI
08/04SOLARA ACTIVE PHARMA SCIENCES' : Consolidated Profit Climbs in Fiscal Q1
MT
08/04Solara Active Pharma Sciences Limited Reports Earnings Results for the First Quarter En..
CI
07/28Solara Active Pharma Sciences Limited Recommends Final Dividend for the Fiscal 2020-21
CI
05/19SOLARA ACTIVE PHARMA SCIENCES' : Promoter Pledge Decreases by 50%
MT
05/07SOLARA ACTIVE PHARMA SCIENCES : Records Surge in Q4
MT
05/06Solara Active Pharma Sciences Limited Recommends Dividend for the Year Ended March 31, ..
CI
05/06Solara Active Pharma Sciences Limited Reports Earnings Results for the Fourth Quarter E..
CI
More news
Financials
Sales 2022 22 576 M 306 M 306 M
Net income 2022 3 682 M 49,9 M 49,9 M
Net Debt 2022 1 686 M 22,9 M 22,9 M
P/E ratio 2022 19,9x
Yield 2022 0,61%
Capitalization 59 022 M 800 M 800 M
EV / Sales 2022 2,69x
EV / Sales 2023 2,24x
Nbr of Employees 2 575
Free-Float 37,8%
Chart SOLARA ACTIVE PHARMA SCIENCES LIMITED
Duration : Period :
Solara Active Pharma Sciences Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SOLARA ACTIVE PHARMA SCIENCES LIMITED
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 1 642,70 INR
Average target price 2 089,25 INR
Spread / Average Target 27,2%
EPS Revisions
Managers and Directors
Bharath R. Sesha Chief Executive Officer & Managing Director
Subhash Anand Chief Financial Officer & Executive Director
Aditya Tapishwar Puri Chairman
Swaminathan Srinivasan Senior VP-Research & Development
Sudhir Nambiar Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
SOLARA ACTIVE PHARMA SCIENCES LIMITED37.86%800
JOHNSON & JOHNSON4.16%431 543
ROCHE HOLDING AG10.05%322 644
PFIZER, INC.19.32%246 414
NOVO NORDISK A/S50.62%232 291
ELI LILLY AND COMPANY35.22%206 972